Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GalenicaGALNF 82 EV-to-EBITDA is 12.45 as of Jul. 26, 2026, which is 4% below its 10-year median of 12.94. GuruFocus rates GALNF with a GF Score™ of 82/100 and a GF Value™ of $114.77. The stock has 1 warning sign investors should review. Among 98 Medical Distribution companies, Galenica ranks worse than 67.35% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Galenica's enterprise value is $5,449 Mil.
Galenica's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $437 Mil. Therefore, Galenica's EV-to-EBITDA for today is 12.45.
The historical rank and industry rank for Galenica's EV-to-EBITDA or its related term are showing as below:
GALNF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.31 Med: 12.94 Max: 18.74
Current: 12.65
During the past 13 years, the highest EV-to-EBITDA of Galenica was 18.74. The lowest was 10.31. And the median was 12.94.
GALNF's EV-to-EBITDA is ranked worse than 67.35% of 98
companies
in the Medical Distribution industry
Industry Median: 8.67
vs GALNF: 12.65
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Galenica (OTCPK:GALNF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Galenica's share price for today is $115.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galenica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $4.511.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Galenica's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Galenica's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Galenica's EV-to-EBITDA falls into.
Galenica's current Enterprise Value is $5,449 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galenica's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $437 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica (GALNF) has a EV-to-EBITDA of 12.45 as of Jul. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Galenica. This is near median its historical median of 12.94. Over the past decade, Galenica's EV-to-EBITDA has ranged from 10.31 to 18.74. According to the industry distribution chart, Galenica ranks #66 out of 98 companies in the Medical Distribution industry, placing it in the top 67.3%.
Is Galenica's EV-to-EBITDA too high?
Galenica's current EV-to-EBITDA of 12.45 is near median its 10-year median of 12.94. Over the past 10 years, this metric has ranged from a low of 10.31 to a high of 18.74. The Medical Distribution industry median EV-to-EBITDA is 8.67. Galenica's value of 12.45 is 43.6% above this industry median. Based on the distribution chart, Galenica ranks #66 out of 98 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Galenica has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's EV-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #66 out of 98 companies for EV-to-EBITDA. This places Galenica in the lower half of its industry. The industry median EV-to-EBITDA is 8.67. Galenica's value of 12.45 is 43.6% above this benchmark. Historically, Galenica's own EV-to-EBITDA has ranged from 10.31 to 18.74 over the past decade. While the company's 10-year median is 12.94 vs. the industry median of 8.67, Galenica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.67, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current EV-to-EBITDA of 12.45 is 43.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Galenica. For the Medical Distribution industry, the median EV-to-EBITDA is 8.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current EV-to-EBITDA is 12.45, which is near median its own 10-year median of 12.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current EV-to-EBITDA of 12.45. The stock's GF Value™ is $114.77, compared to a current price of $115.00 — trading 0.2% above its estimated fair value. The current EV-to-EBITDA is 12.45, which is near median its 10-year median of 12.94 and 43.6% above the Medical Distribution industry median of 8.67. Galenica's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Galenica (GALNF), the current EV-to-EBITDA is 12.45 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be overvalued.
The current stock price of $115.00 is trading 0.2% above its estimated GF Value™ of $114.77.
Key valuation signals for GALNF:
EV-to-EBITDA: 12.45 (near median its 10-year median of 12.94)
GF Value™: $114.77 vs. price of $115.00 (0.2% above fair value)
Industry Position: 43.6% above the Medical Distribution median (#66 of 98)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
82GF Score
Get the complete analysis for GALNF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
